Selective use of staging laparoscopy based on carbohydrate antigen 19-9 level and tumor size in patients with radiographically defined potentially or borderline resectable pancreatic cancer

Pancreas

Volumn 40, Issue 3, 2011, Pages 426-432

  Satoi, Sohei ^a   Yanagimoto, Hiroaki ^a   Toyokawa, Hideyoshi ^a   Inoue, Kentaro ^a   Wada, Keita ^b   Yamamoto, Tomohisa ^a   Hirooka, Satoshi ^a   Yamaki, So ^a   Yui, Rintaro ^a   Mergental, Hynek ^a   Kwon, A Hon ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CA 19 9; occult distant metastasis; pancreatic cancer; staging laparoscopy; tumor size

Indexed keywords

ALBUMIN; BILIRUBIN; CA 19-9 ANTIGEN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOLOGY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISTANT METASTASIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; LAPAROSCOPY; LAPAROTOMY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBSTRUCTIVE JAUNDICE; OPERATION DURATION; PANCREAS CANCER; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURGICAL MORTALITY; ULTRASOUND;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; FEMALE; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79954425815     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182056b1c     Document Type: Article

References (27)

1. Takai S, Satoi S, Toyokawa H, et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas. 2003;26:243-249. (Pubitemid 36384156)
2. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236:355-366.
3. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg. 2003;237:74-85. (Pubitemid 36622320)
4. Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg. 1998;228:508-517.
5. Satoi S, Yanagimoto H, Toyokawa H, et al. Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer. Pancreas. 2009;38:282-288.
6. Ohigashi H, Ishikawa O, Eguchi H, et al. Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer. Ann Surg. 2009;250:88-95.
7. Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008;26:3496-3502.
8. Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet. 2004;363:1049-1057. (Pubitemid 38410779)
9. White R, Winston C, Gonen M, et al. Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. J Am Coll Surg. 2008;206:445-450. (Pubitemid 351282524)
10. Satoi S, Yamamoto H, Takai S, et al. Clinical impact of multidetector row computed tomography on patients with pancreatic cancer. Pancreas. 2007;34:175-179. (Pubitemid 46294791)
11. Stefanidis D, Grove KD, Schwesinger WH, et al. The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. Ann Oncol. 2006;17:189-199. (Pubitemid 43160105)
12. Morganti AG, Brizi MG, Macchia G, et al. The prognostic effect of clinical staging in pancreatic adenocarcinoma. Ann Surg Oncol. 2005;12:145-151. (Pubitemid 40486623)
13. Schlieman MG, Ho HS, Bold RJ, et al. Utility of tumor markers in determining resectability of pancreatic cancer. Arch Surg. 2003;138:951-955.
14. Mann DV, Edwards R, Ho S, et al. Elavated tumour marker CA19.9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol. 2000;26:474-479.
15. National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2005;3(5):598.
16. Lillemoe KD, Cameron JL, Yeo CJ, et al. Pancreaticoduodenectomy does it have a role in the palliation of pancreatic cancer. Ann Surg. 1996;6:718-728. (Pubitemid 26185216)
17. Nitecki SS, Sarr MG, Colby TV, et al. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg. 1995;221:59-66.
18. Jimenez RE, Warshaw AL, Rattner DW, et al. Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg. 2000;135:409-414.
19. Ellsmere J, Mortele K, Sahani D, et al. Does multidetector-row CT eliminate the role of diagnostic laparoscopy in assessing the resectability of pancreatic head adenocarcinoma? Surg Endosc. 2005;19:369-373.
20. Liu RC, Traverso LW. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc. 2005;19:638-642. (Pubitemid 40898005)
21. Prokesch RW, Chow LC, Beaulieu CF, et al. Local staging of pancreatic carcinoma with multi-detector row CT: use of curved planar reformations initial experience. Radiology. 2002;225:759-765. (Pubitemid 35387114)
22. Vargas R, Nino-Murcia M, Trueblood W, et al. MDCT in pancreatic adenocarcinoma: prediction of vascular involvement and resectability using a multiphasic technique with curved planar reformations. AJR. 2004;182:419-425. (Pubitemid 38116586)
23. Pisters PW, Lee JE, Vauthey JN, et al. Laparoscopy in the staging of pancreatic cancer. Br J Surg. 2001;88:325-337. (Pubitemid 32238693)
24. Tilleman EHBM, Busch ORC, Bemelman WA, et al. Diagnostic laparoscopy in staging pancreatic carcinoma: developments during past decades. J Hepatobiliary Pancreat Surg. 2004;11:11-16. (Pubitemid 38404326)
25. Mayo SC, Austin DF, Sheppard BC, et al. Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era? J Am Coll Surg. 2009;208:87-95.
26. Connor S, Bosonnet L, Alexakis N, et al. Serum CA19-9 measurement increases the effectiveness of staging laparoscopy in patients with suspected pancreatic malignancy. Dig Surg. 2005;22:80-85. (Pubitemid 40754696)
27. Kang CM, Kim JY, Choi GH, et al. The use of adjusted pre-operative CA19-9 to predict the recurrence of resectable pancreatic cancer. J Surg Res. 2007;140:31-35. (Pubitemid 46669540)